Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206-8215].
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI